A carregar...

Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study

AIM: Previously, we reported on the efficacy and safety of guanfacine extended‐release (GXR) in Japanese adults with attention‐deficit/hyperactivity disorder (ADHD) from a phase 3, double‐blind, placebo‐controlled, randomized trial. In this exploratory post hoc analysis, we assessed the efficacy and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychopharmacol Rep
Main Authors: Naya, Noriyuki, Sakai, Chika, Okutsu, Daiki, Kiguchi, Ryo, Fujiwara, Masakazu, Tsuji, Toshinaga, Iwanami, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8182954/
https://ncbi.nlm.nih.gov/pubmed/33305542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/npr2.12152
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!